GENEVA, May 19 (Xinhua) -- The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinovac having been certified by WHO Emergency Use Listing (EUL).
点击右上角微信好友
朋友圈
请使用浏览器分享功能进行分享